Last update 27 Jun 2026

SYH2069

Overview

Basic Info

Drug Type
Chemical drugs, Peptides
Synonyms
SYH2069
Target
GIPR x GLP-1R
Action
agonists
Mechanism
GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
ObesityDiabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Beijing Kangchuanglian Biopharmaceutical Technology ResearchCSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
Active Organization
Beijing Kangchuanglian Biopharmaceutical Technology ResearchCSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Pharmaceutical Group Ltd.CSPC Pharmaceutical Group Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SYH2069
CTR20255220
/ RecruitingPhase 1
一项随机、双盲、安慰剂对照、剂量递增，评价SYH2069注射液在健康受试者中单次和多次给药的安全性、耐受性、药代动力学和药效动力学的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation phase I clinical study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of SYH2069 injection in healthy subjects after single and multiple administrations.
100 Clinical Results associated with SYH2069
Login to view more data
100 Translational Medicine associated with SYH2069
Login to view more data
100 Patents (Medical) associated with SYH2069
Login to view more data
100 Deals associated with SYH2069
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityPhase 1
China
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
08 Jan 2026
ObesityPhase 1
China
Beijing Kangchuanglian Biopharmaceutical Technology Research
08 Jan 2026
Diabetes Mellitus, Type 2IND Approval
China
Beijing Kangchuanglian Biopharmaceutical Technology Research
08 Apr 2026
Diabetes Mellitus, Type 2IND Approval
China
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
08 Apr 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free